Category Archives: MS Treatment

Doctors believe they are closer to a treatment for multiple sclerosis after discovering a drug that repairs the coatings around nerves that are damaged by the disease. A clinical trial of the cancer drug bexarotene showed that it repaired the protective myelin sheaths that MS destroys Continue reading →

In patients with active relapses during secondary progressive multiple sclerosis (SPMS), treatment with disease-modifying therapies (DMTs) may slow the rate of disability accumulation, according to study results published in JAMA Neurology. Additionally, the study findings indicated that the rate of disability progression following disease onset was not dependent on early disease course/treatment. There is limited data available regarding the association of relapses and DMTs with the rate of disability accumulation in patients with SPMS. Continue reading →

NORTH CHICAGO, Ill., Sept. 28, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an investigational treatment for patients following spinal cord injury. Continue reading →

Sept. 27, 2020 7:00 am ET Community members in the Khayelitsha township in Cape Town, South Africa, work to rebuild their homes. Amid the coronavirus, police are tearing down shacks built on public land by people who can no longer pay rent on their previous homes Continue reading →

Newswise Background: Coronavirus disease 19 (COVID-19) is the most globally impactful pandemic of the past century. The causative pathogen, SARS-CoV-2, infects ACE2-expressing cells and leads to pulmonary disease and a systemic immune response. Continue reading →

"I am thrilled to welcome Lizette to our Board of Directors," said Tom Seery, RealSelf founder and chief executive officer. "Her marketing and advertising experience will accelerate our drive to grow the RealSelf brand and innovate in a way that's relevant to our customers and to our partners Continue reading →

A new business intelligence report released by Data Bridge Market Research with title Global Multiple Sclerosis Market are taken from trustworthy sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts. Market research report is always helpful to business or organization in every subject of trade for taking better decisions, solving the toughest business questions and minimizing the risk of failure. Continue reading →

Five months ago, I wrote about my sister, a junior doctor at a large hospital, and my fears for her as she worked on what is frequently described as the frontline of the Covid-19 crisis, as if she were a soldier at war, as opposed to someone who just wanted to make people feel better. Well, grab me a turban and call me Mystic Meg, because youll never guess what happened next Continue reading →

(Part 2of 4) In this video, Psych Congress2020 cochair Vladimir Maletic, MD, MS, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity disorder (ADHD) and strategies for treating them. Dr. Continue reading →

SAN FRANCISCO and SUZHOU, China, Sept. 28, 2020 /PRNewswire/ -- Innovent Biologics, Inc Continue reading →